SH

Suresh Hila Bhamre

Director Director DIN 02962941
DIN 02962941 First appointment May 2010 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2010
Shareholding value Locked Premium profile

About Suresh Hila Bhamre

Suresh Hila Bhamre has 16 years in corporate governance. Formerly with 1 company, such as Caliber Drugs (India) Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02962941
Primary Designation Director
First Appointment 13 May 2010
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 13 May 2010 2001 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Caliber Drugs (India) Private Limited
Premium access

Shareholding and investment profile for Suresh Hila Bhamre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Hila Bhamre

Suresh Hila Bhamre has 16 years in corporate governance. Formerly with 1 company, such as Caliber Drugs (India) Private Limited. Engaged in General Business. Contributes to corporate operations.

Suresh Hila Bhamre is associated with 0 companies as a director.

Suresh Hila Bhamre has expertise in General Business.

Suresh Hila Bhamre has 16 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available